​

INmune Bio (INMB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

INmune Bio Revenue Highlights

Latest Revenue (Y)

$14.00K

Latest Revenue (Q)

$50.00K

INmune Bio Revenue by Period

INmune Bio Revenue by Year

DateRevenueChange
2024-12-31$14.00K-90.97%
2023-12-31$155.00K-58.56%
2022-12-31$374.00K106.63%
2021-12-31$181.00K1558.12%
2020-12-31$10.92K-99.99%
2019-12-31$77.69M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

INmune Bio generated $14.00K in revenue during NA 2024, up -90.97% compared to the previous quarter, and up 0.02% compared to the same period a year ago.

INmune Bio Revenue by Quarter

DateRevenueChange
2025-03-31$50.00K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$14.00K-50.00%
2023-12-31$28.00K-34.88%
2023-09-30$43.00K-6.52%
2023-06-30$46.00K21.05%
2023-03-31$38.00K-60.82%
2022-12-31$97.00K-1.02%
2022-09-30$98.00K512.50%
2022-06-30$16.00K-90.18%
2022-03-31$163.00K-
2021-12-31$163.00K1064.29%
2021-09-30$14.00K100.00%
2021-06-30--100.00%
2021-03-31$4.00K-63.36%
2020-12-31$10.92K100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

INmune Bio generated $50.00K in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 178.57% compared to the same period a year ago.

INmune Bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KPTIKaryopharm Therapeutics$145.24M$37.93M
MRSNMersana Therapeutics$40.50M$3.06M
CELUCelularity$22.77M$18.13M
BRNSBarinthus Biotherapeutics$14.97M-
BTAIBioXcel Therapeutics$2.27M$120.00K
QTTBQ32 Bio$1.16M-
EVAXEvaxion Biotech$73.11K$50.88K
INMBINmune Bio$14.00K$50.00K
BCABBioAtla--
TPSTTempest Therapeutics--

INMB Revenue FAQ

What is INmune Bio’s yearly revenue?

INmune Bio's yearly revenue for 2024 was $14K, representing a decrease of -90.97% compared to 2023. The company's yearly revenue for 2023 was $155K, representing a decrease of -58.56% compared to 2022. INMB's yearly revenue for 2022 was $374K, representing an increase of 106.63% compared to 2021.

What is INmune Bio’s quarterly revenue?

INmune Bio's quarterly revenue for Q1 2025 was $50K, a 100.00% increase from the previous quarter (Q4 2024), and a 257.14% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $0, a 100.00% increase from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). INMB's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023).

What is INmune Bio’s revenue growth rate?

INmune Bio's revenue growth rate for the last 3 years (2022-2024) was -96.26%, and for the last 5 years (2020-2024) was 28.25%.